Free Trial

TerrAscend (OTCMKTS:TSNDF) Shares Up 3.6% - What's Next?

TerrAscend logo with Medical background

TerrAscend Corp. (OTCMKTS:TSNDF - Get Free Report) shares traded up 3.6% on Wednesday . The stock traded as high as $0.27 and last traded at $0.26. 235,045 shares changed hands during trading, a decline of 54% from the average session volume of 507,821 shares. The stock had previously closed at $0.25.

Wall Street Analysts Forecast Growth

Separately, Atb Cap Markets raised shares of TerrAscend from a "hold" rating to a "strong-buy" rating in a research report on Thursday, May 8th.

View Our Latest Stock Report on TerrAscend

TerrAscend Stock Down 2.2%

The firm has a market cap of $76.96 million, a PE ratio of -0.93 and a beta of 1.43. The company has a debt-to-equity ratio of 1.42, a quick ratio of 0.70 and a current ratio of 1.31. The company's 50-day simple moving average is $0.33 and its two-hundred day simple moving average is $0.45.

TerrAscend (OTCMKTS:TSNDF - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.02). The firm had revenue of $71.00 million for the quarter, compared to analysts' expectations of $71.63 million. TerrAscend had a negative net margin of 25.27% and a negative return on equity of 20.23%. On average, analysts predict that TerrAscend Corp. will post -0.14 earnings per share for the current fiscal year.

TerrAscend Company Profile

(Get Free Report)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.

Recommended Stories

Should You Invest $1,000 in TerrAscend Right Now?

Before you consider TerrAscend, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.

While TerrAscend currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines